or Try an Advanced Search...

    Neurological Disorders Stocks List

    Symbol Grade Name % Change
    PMN F ProMIS Neurosciences Inc. -3.01
    MYO F Myomo Inc. 0.36
    FLGT F Fulgent Genetics, Inc. -0.25
    RLMD F Relmada Therapeutics, Inc. 0.67
    IKT F Inhibikase Therapeutics, Inc. -4.92
    PRTA F Prothena Corporation plc -1.57
    OVID F Ovid Therapeutics Inc. -2.81
    ADXN F Addex Therapeutics Ltd 0.00
    AEMD F Aethlon Medical, Inc. -4.24
    TVGN F Tevogen Bio Holdings Inc. -3.53
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Devices Scientific & Technical Instruments
    Related Stock Lists: Parkinson's Disease Alzheimer's Disease Biology Dementia Amyotrophic Lateral Sclerosis Biopharmaceutical Degenerative Disease Lewy Body Dementia Neurodegeneration Neurodegenerative Diseases Organ Systems Psychiatric Diagnosis Urological Disorders Aging Associated Diseases Alpha Synuclein Cancer Disease Fragile X Syndrome Glaucoma Infectious Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Neurological Disorders stocks.

    Symbol Grade Name Weight
    PSIL F AdvisorShares Psychedelics ETF 4.92
    IBRN D iShares Neuroscience and Healthcare ETF 1.95
    GERM D ETFMG Treatments Testing and Advancements ETF 1.42
    HTEC D Robo Global Healthcare Technology and Innovation ETF 1.33
    SBIO D ALPS Medical Breakthroughs ETF 1.28
    View all Neurological Disorders ETFs...
    Compare ETFs
    Compare GERM to HTEC Compare IBRN to GERM Compare PSIL to IBRN

        Neurological Disorders Stocks Recent News

        Date Stock Title
        Jul 1 OVID Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
        Jul 1 ADXN Addex Shareholders Approve All Resolutions at Annual General Meeting
        Jun 29 FLGT With 50% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing
        Jun 28 AEMD Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2024 Earnings Call Transcript
        Jun 27 AEMD Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript
        Jun 27 AEMD Aethlon Medical GAAP EPS of -$4.86 beats by $0.33
        Jun 27 AEMD Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Devices Scientific & Technical Instruments
        Related Stock Lists: Urological Disorders Biology Amyotrophic Lateral Sclerosis Cancer Dementia Disease Lewy Body Dementia Parkinson's Disease Aging Associated Diseases Alpha Synuclein Alzheimer's Disease Biopharmaceutical Biotechnology Infectious Diseases Medicine Multiple System Atrophy Neuroscience Organ Systems Psychiatric Diagnosis Algorithms
        Neurological Disorders

        Neurological disorders are conditions that affect the nervous system, which includes the brain, spinal cord, and nerves. These disorders can affect how the body functions, including movement, speech, and memory. Examples of neurological disorders include Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, epilepsy, and migraine.

        Browse All Tags